Meeder Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-233
| Closed | -$4.79K | – | 984 |
|
|
2024
Q3 | $4.79K | Buy |
233
+84
| +56% | +$1.73K | ﹤0.01% | 747 |
|
|
2024
Q2 | $3.34K | Buy |
149
+26
| +21% | +$582 | ﹤0.01% | 816 |
|
|
2024
Q1 | $3.38K | Buy |
+123
| New | +$3.38K | ﹤0.01% | 686 |
|
|
2021
Q4 | – | Sell |
-1,931
| Closed | -$258K | – | 1947 |
|
|
2021
Q3 | $258K | Sell |
1,931
-151
| -7% | -$20.2K | 0.01% | 648 |
|
|
2021
Q2 | $337K | Buy |
2,082
+318
| +18% | +$51.5K | 0.02% | 610 |
|
|
2021
Q1 | $142K | Buy |
+1,764
| New | +$142K | 0.01% | 820 |
|
|
2020
Q4 | – | Sell |
-3,517
| Closed | -$69K | – | 2116 |
|
|
2020
Q3 | $69K | Sell |
3,517
-343
| -9% | -$6.73K | ﹤0.01% | 885 |
|
|
2020
Q2 | $80K | Buy |
3,860
+3,753
| +3,507% | +$77.8K | 0.01% | 812 |
|
|
2020
Q1 | $1K | Buy |
+107
| New | +$1K | ﹤0.01% | 2206 |
|
|
2019
Q3 | – | Sell |
-119
| Closed | -$2K | – | 2231 |
|
|
2019
Q2 | $2K | Buy |
+119
| New | +$2K | ﹤0.01% | 1874 |
|
|
2018
Q4 | – | Sell |
-11
| Closed | – | – | 1768 |
|
|
2018
Q3 | $0 | Buy |
+11
| New | – | ﹤0.01% | 1641 |
|
|
2018
Q2 | – | Sell |
-77
| Closed | -$2K | – | 1640 |
|
|
2018
Q1 | $2K | Sell |
77
-218
| -74% | -$5.66K | ﹤0.01% | 1383 |
|
|
2017
Q4 | $6K | Buy |
295
+126
| +75% | +$2.56K | ﹤0.01% | 1266 |
|
|
2017
Q3 | $4K | Sell |
169
-149
| -47% | -$3.53K | ﹤0.01% | 1326 |
|
|
2017
Q2 | $5K | Sell |
318
-69
| -18% | -$1.09K | ﹤0.01% | 1196 |
|
|
2017
Q1 | $5K | Hold |
387
| – | – | ﹤0.01% | 1081 |
|
|
2016
Q4 | $5K | Buy |
+387
| New | +$5K | ﹤0.01% | 857 |
|